TY - JOUR
T1 - Phenotypic variability associated with progranulin haploinsufficiency in patients with the common 1477C→T (Arg493X) mutation: an international initiative
AU - Rademakers, Rosa
AU - Baker, Matt
AU - Gass, Jennifer
AU - Adamson, Jennifer
AU - Huey, Edward D.
AU - Momeni, Parastoo
AU - Spina, Salvatore
AU - Coppola, Giovanni
AU - Karydas, Anna M.
AU - Stewart, Heather
AU - Johnson, Nancy
AU - Hsiung, Ging Yuek
AU - Kelley, Brendan
AU - Kuntz, Karen
AU - Steinbart, Ellen
AU - Wood, Elisabeth McCarty
AU - Yu, Chang En
AU - Josephs, Keith
AU - Sorenson, Eric
AU - Womack, Kyle B.
AU - Weintraub, Sandra
AU - Pickering-Brown, Stuart M.
AU - Schofield, Peter R.
AU - Brooks, William S.
AU - Van Deerlin, Vivianna M.
AU - Snowden, Julie
AU - Clark, Christopher M.
AU - Kertesz, Andrew
AU - Boylan, Kevin
AU - Ghetti, Bernardino
AU - Neary, David
AU - Schellenberg, Gerard D.
AU - Beach, Thomas G.
AU - Mesulam, Marsel
AU - Mann, David
AU - Grafman, Jordan
AU - Mackenzie, Ian R.
AU - Feldman, Howard
AU - Bird, Thomas
AU - Petersen, Ron
AU - Knopman, David
AU - Boeve, Bradley
AU - Geschwind, Dan H.
AU - Miller, Bruce
AU - Wszolek, Zbigniew
AU - Lippa, Carol
AU - Bigio, Eileen H.
AU - Dickson, Dennis
AU - Graff-Radford, Neill
AU - Hutton, Mike
PY - 2007/10
Y1 - 2007/10
N2 - Background: The progranulin gene (GRN) is mutated in 5-10% of patients with frontotemporal lobar degeneration (FTLD) and in about 20% of patients with familial FTLD. The most common mutation in GRN is Arg493X. We aimed to establish the contribution of this mutation to FTLD and related disorders. Methods: We measured the frequency of Arg493X in 3405 unrelated patients with various neurodegenerative diseases using Taqman single-nucleotide polymorphism (SNP) genotyping. Clinicopathological characterisation and shared haplotype analysis were done for 30 families with FTLD who carry Arg493X. To investigate the effect of potential modifying loci, we did linear regression analyses with onset age as the covariate for GRN variants, for genotypes of the apolipoprotein E gene (APOE), and for haplotypes of the microtubule-associated protein tau gene (MAPT). Findings: Of 731 patients with FTLD, 16 (2%) carried Arg493X. This mutation was not detected in 2674 patients who did not have FTLD. In 37 patients with Arg493X from 30 families with FTLD, clinical diagnoses included frontotemporal dementia, primary progressive aphasia, corticobasal syndrome, and Alzheimer's disease. Range of onset age was 44-69 years. In all patients who came to autopsy (n=13), the pathological diagnosis was FTLD with neuronal inclusions that contained TAR DNA-binding protein or ubiquitin, but not tau. Neurofibrillary tangle pathology in the form of Braak staging correlated with overall neuropathology in the Arg493X carriers. Haplotype analyses suggested that Arg493X arose twice, with a single founder for 27 families. Linear regression analyses suggested that patients with SNP rs9897528 on their wild-type GRN allele have delayed symptom onset. Onset ages were not associated with the MAPT H1 or H2 haplotypes or APOE genotypes, but early memory deficits were associated with the presence of an APOE ε4 allele. Interpretation: Clinical heterogeneity is associated with GRN haploinsufficiency, and genetic variability on the wild-type GRN allele might have a role in the age-related disease penetrance of GRN mutations. © 2007 Elsevier Ltd. All rights reserved.
AB - Background: The progranulin gene (GRN) is mutated in 5-10% of patients with frontotemporal lobar degeneration (FTLD) and in about 20% of patients with familial FTLD. The most common mutation in GRN is Arg493X. We aimed to establish the contribution of this mutation to FTLD and related disorders. Methods: We measured the frequency of Arg493X in 3405 unrelated patients with various neurodegenerative diseases using Taqman single-nucleotide polymorphism (SNP) genotyping. Clinicopathological characterisation and shared haplotype analysis were done for 30 families with FTLD who carry Arg493X. To investigate the effect of potential modifying loci, we did linear regression analyses with onset age as the covariate for GRN variants, for genotypes of the apolipoprotein E gene (APOE), and for haplotypes of the microtubule-associated protein tau gene (MAPT). Findings: Of 731 patients with FTLD, 16 (2%) carried Arg493X. This mutation was not detected in 2674 patients who did not have FTLD. In 37 patients with Arg493X from 30 families with FTLD, clinical diagnoses included frontotemporal dementia, primary progressive aphasia, corticobasal syndrome, and Alzheimer's disease. Range of onset age was 44-69 years. In all patients who came to autopsy (n=13), the pathological diagnosis was FTLD with neuronal inclusions that contained TAR DNA-binding protein or ubiquitin, but not tau. Neurofibrillary tangle pathology in the form of Braak staging correlated with overall neuropathology in the Arg493X carriers. Haplotype analyses suggested that Arg493X arose twice, with a single founder for 27 families. Linear regression analyses suggested that patients with SNP rs9897528 on their wild-type GRN allele have delayed symptom onset. Onset ages were not associated with the MAPT H1 or H2 haplotypes or APOE genotypes, but early memory deficits were associated with the presence of an APOE ε4 allele. Interpretation: Clinical heterogeneity is associated with GRN haploinsufficiency, and genetic variability on the wild-type GRN allele might have a role in the age-related disease penetrance of GRN mutations. © 2007 Elsevier Ltd. All rights reserved.
KW - Age of Onset
KW - Aged
KW - Alleles
KW - genetics: Alzheimer Disease
KW - genetics: Aphasia, Primary Progressive
KW - genetics: Apolipoproteins E
KW - Cohort Studies
KW - metabolism: DNA-Binding Proteins
KW - epidemiology: Dementia
KW - Female
KW - Founder Effect
KW - Genotype
KW - Haplotypes
KW - Heterozygote
KW - Humans
KW - pathology: Inclusion Bodies
KW - genetics: Intercellular Signaling Peptides and Proteins
KW - Male
KW - epidemiology: Memory Disorders
KW - Middle Aged
KW - Mutation
KW - epidemiology: Neurodegenerative Diseases
KW - pathology: Neurofibrillary Tangles
KW - pathology: Neurons
KW - Phenotype
KW - Polymorphism, Single Nucleotide
KW - Retrospective Studies
KW - metabolism: Ubiquitin
KW - genetics: tau Proteins
U2 - 10.1016/S1474-4422(07)70221-1
DO - 10.1016/S1474-4422(07)70221-1
M3 - Article
SN - 1474-4422
VL - 6
SP - 857
EP - 868
JO - The Lancet Neurology
JF - The Lancet Neurology
IS - 10
ER -